Table 1.
Clinical and demographic data of autoimmune thyroid disease (ATD) patients (n = 154)
| Gender, female, n (%) | 139 (90.2) |
| Age, years, mean ± SD | 45.3±14.21 |
| Ethnic background, n (%) | |
| Caucasian | 118 (75.5) |
| Afro-descendants | 35 (22.7) |
| Asiatic | 1 (0.6) |
| Tobacco exposure, n (%) | 46 (29.8) |
| Alcohol ingesting, n (%) | 6 (3.8) |
| Graves/Hashimoto, n (%) | 84 (54.5)/70 (45.4) |
| Treatment | |
| Thyroid replacement, n (%) | 127 (82.4) |
| Thyroid replacement, dose, µg/kg/day, mean ± SD |
0.31–4.42 (1.65±0.71) |
| Tapazole, n (%) | 12 (7.7) |
| Propylthiouracil, n (%) | 3 (1.9) |
| None, n (%) | 12 (7.7) |